Revised Draft Guidelines for Examination of Patent Applications in the Pharma Industry

The revised draft guidelines for examining pharmaceutical patent applications in India aim to standardize practices and clarify legal provisions, particularly section 3(d). These guidelines reflect stakeholder input and are designed to address the complexities unique to the pharmaceutical sector.

Read more about Revised Draft Guidelines for Examination of Patent Applications in the Pharma Industry

Anticipation – Mere Presence of Elements Insufficient; Arrangement of Elements Imperative

This analysis addresses the requirement for both the presence and arrangement of claim elements in anticipation under patent law, drawing from the Net MoneyIN v. Verisign case. The Federal Circuit clarified that combining separate disclosures within a single prior art reference is insufficient to establish anticipation.

Read more about Anticipation – Mere Presence of Elements Insufficient; Arrangement of Elements Imperative

Patents May be Relatively New to Indians, but Inventions are Not

This post highlights Mr. C T Dwarakanath’s 1971 US patent for a novel ozone-based method to reduce aflatoxin in oilseed meals. It underscores the significant contribution of Indian inventors to global agricultural innovation and reflects on the legacy of scientific excellence from India.

Read more about Patents May be Relatively New to Indians, but Inventions are Not